Peptides and Hair-Related Claims

"Hair growth peptides" is a marketing phrase, not a single treatment. It covers different ingredients, in different products, for different kinds of hair loss. This page checks what published research supports. It is education only and does not recommend any product.

Start with the cause of hair loss

Hair loss has many causes. The NHS notes that some types are permanent, such as male and female pattern baldness, while others can be temporary and follow illness, stress, cancer treatment, weight loss or iron deficiency. [1] It advises seeing a GP to learn the cause before thinking about a commercial hair clinic. [1] A serum that suits one cause may do nothing for another. See pattern hair loss and hair shedding and thinning.

What the standard options are

For male pattern baldness, the NHS names finasteride and minoxidil as the main treatments. [1] Minoxidil can also be used for female pattern baldness, and women should not use finasteride. [1] These treatments do not work for everyone and only work for as long as they are used. [1] Any peptide product has to be judged against this baseline, not against nothing. Talk with a clinician about medicines. This page does not tell anyone to start, stop or change one.

What the peptide research actually covers

1. Laboratory work on a copper peptide (preclinical). A 2007 study tested a copper-bound three-amino-acid peptide called AHK-Cu on human hair follicles kept in culture and on cultured hair-papilla cells. It reported longer follicles and more cell growth. [2] This is preclinical work and does not show that a cream grows hair on a scalp. Note also that AHK-Cu is not the same sequence as GHK-Cu, the copper peptide discussed more often. Compare GHK-Cu: identity and claims.

2. Branded ingredient complexes (promising but limited). A 2025 review of hair-loss topicals describes ingredient brands such as Procapil and Capixyl. Procapil is a blend of three active substances, one of which is a three-amino-acid peptide called biotinyl-GHK. [3] The review summarizes small trials. In one with 30 men, a 5% Capixyl lotion raised the anagen to telogen ratio by 46% against a 33% fall with placebo. [3] In another small randomized study, a herbal blend containing acetyl tetrapeptide-3 was compared with 3% minoxidil. [3] Those results are reported as secondhand figures from a review. I did not read the trials.

The same review cautions that most studies have limited sample size, no comparison with standard therapies, uneven study groups, no disclosure of the type of alopecia treated, and conflicts of interest. [3] Because these are blends, a result cannot be credited to one peptide. See ingredient evidence vs finished-product evidence.

3. Injected or "clinic" peptides for hair. Proper evidence not found. I searched PubMed on 2026-10-22 for peptide hair growth clinical trials, copper peptide hair growth and hair-growth cosmeceutical peptide reviews. I found no human randomized trial of a single named peptide ingredient for hair outside the branded-complex studies above. Injectables belong with the safety concerns on peptide safety and adverse events.

Claims that go beyond the evidence

• "Clinically proven to regrow hair" is a marketing claim unless the study tested that exact product, in the type of hair loss you have, against a fair comparison.
• A lab result on follicle cells is not hair on a scalp.
• A cosmetic that claims to change the body's structure or function is, in FDA's description, a drug. [4] In the European Commission's wording, a product that restores, corrects or modifies body functions through a pharmacological action is a medicinal product. [5] Whether a given serum meets that test depends on its claims and ingredients and was not checked here.
• Cosmetic products in the United States do not need FDA premarket approval. [4]